EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark Medigene Immunotherapies was filed as Word mark on 10/28/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 03/18/2021.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018327910 |
| Application date | October 28, 2020 |
| Publication date | December 9, 2020 |
| Entry date | March 18, 2021 |
| Expiration date | October 28, 2030 |
Trademark owner
Lochhamerstr. 11
82152 Planegg-Martinsried
DE
82152 Planegg-Martinsried
DE
Trademark representatives
Josephspitalstr. 15
80331 München
DE
goods and services
1
Nucleic acids
5
Medicines for humans and animals, Vaccines, Serums, Test kits and Diagnostic preparations, In particular manufactured using molecular biological, genetic engineering and biotechnological methods; proteins, Cell products, Protein conjugates, Peptides, Enzymes and enzyme preparations, In particular antibodies and T-cell proteins; T-cells, Dendritic cells and other immune system cells, viruses and Particles similar to viruses; Liposomes; Plant extracts; Low-molecular active substances; Medicines, Vaccines, Adjuvants, Serums, Test kits and Diagnostic agents relating to precancerous cells, benign and malignant tumours, in particular haematological tumours, inflammatory disorders, neurodegenerative disorders, Autoimmune conditions and Immunotherapy
42
Molecular biology and biotechnology laboratory services, In particular research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, genetic engineering and biotechnological methods, and in the field of screening for pharmaceutically active components; Development of test procedures and test kits in the field of biotechnology and medicine
44
Medical analysis and medical consulting in connection with the treatment of individuals, In particular in the field of precancerous cells, benign and malignant tumours, autoimmune diseases and Immunotherapy
45
Licensing of intellectual property, Including trademarks and patents in the field of biotechnology, pharmacy and medicine
ID: 11018327910